TALIDOMIDA ACCORD 50 mg रोमानिया - रोमानियाई - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

talidomida accord 50 mg

idifarma desarrollo farmaceutico s.l. - spania - talidomidum - caps. - 50mg - imunosupresoare alte imunosupresoare

Kesimpta यूरोपीय संघ - रोमानियाई - EMA (European Medicines Agency)

kesimpta

novartis ireland ltd - ofatumumab - scleroză multiplă, scleroză multiplă recurent-remisivă - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.

LENALIDOMIDA TERAPIA 10 mg रोमानिया - रोमानियाई - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lenalidomida terapia 10 mg

sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 10mg - imunosupresoare alte imunosupresoare

LENALIDOMIDA TERAPIA 15 mg रोमानिया - रोमानियाई - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lenalidomida terapia 15 mg

sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 15mg - imunosupresoare alte imunosupresoare

LENALIDOMIDA TERAPIA 20 mg रोमानिया - रोमानियाई - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lenalidomida terapia 20 mg

sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 20mg - imunosupresoare alte imunosupresoare

LENALIDOMIDA TERAPIA 5 mg रोमानिया - रोमानियाई - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lenalidomida terapia 5 mg

sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 5mg - imunosupresoare alte imunosupresoare

LENALIDOMIDA TERAPIA 7,5 mg रोमानिया - रोमानियाई - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lenalidomida terapia 7,5 mg

sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 7,5mg - imunosupresoare alte imunosupresoare

Thalidomide Lipomed यूरोपीय संघ - रोमानियाई - EMA (European Medicines Agency)

thalidomide lipomed

lipomed gmbh - thalidomide - mielom multiplu - imunosupresoare - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

Briumvi यूरोपीय संघ - रोमानियाई - EMA (European Medicines Agency)

briumvi

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresoare - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.